Влияние терапии, основанной на комбинации небиволола с моэксиприлом, на сосудистые и иммунологические показатели у больных хронической сердечной недостаточностью, обусловленной ишемической болезнью сердца

Е. С. Яровова, Кастанаян Александр Алексианосович, Igor Ivanov · Современные проблемы науки и образования · 2012

A clinical study on 78 patients with chronic heart failure, ischemic origin, it has been proven that therapy of cardiac insufficiency with the inclusion of nebivolol and moexipril at low and high functional classes of diseases to affect the structural and functional parameters of vessels, providing increased amplitude of dilatation vessels, reducing stiffness and elastic pressure of the vascular wall of the arteries and increase capacitive resistive properties of elastic blood vessels. Therapy based on combination of nebivolol and moexipril regardless of the functional class of chronic heart failure reduces the concentration of proinflammatory cytokines in the blood, and high functional class, accompanied by a decrease in plasma levels of markers of fibrosis transforming growth factor-β1.

Cited by 0 works.

Authors